Respiratory and Pulmonary System Chronic Obstructive Pulmonary Disease
Life Science Analytics, March 2008, Pages: 184
"Respiratory and Pulmonary System Chronic Obstructive Pulmonary Disease " contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of allergy drugs by company and by stage as well as a summary of the latest news and developments in this area.
Scope of the report:
Each ’ Therapy Area Pipeline Report provides the user with real detail on drug pipelines, by company and by stage, for each specific therapy area. The latest news, by company, also ensures that each report is fresh and up-to-date.
In addition to new developments and disease specific pipeline projects, each report also contains extensive information in tabular format on a company’s full product pipeline and products by phase of development with regard to the therapy area.
Full pipeline details, by stage, are provided and include detailed product descriptions, information on partnering activity plus clinical trial intelligence. Each Therapy Area Pipeline Report also provides detail on the top 20 companies with products in the early stage of development and the top 20 companies with products in the late stage of development. Finally, each report also provides a comparison with other major indications in the disease hub based on Marketed Products vs. Pipeline Products.
Key benefits
- Understand a company’s strategic position by accessing detailed independent intelligence on its product pipeline for specific therapy areas.
- Keep track of your competitors and partners by better understanding their product pipeline.
- Monitor a company’s research effectiveness by determining pipeline depth and number of products in development by clinical phase for specific disease areas.
- Maintain a critical competitive advantage.
RECENT HIGHLIGHTS AND CHANGES
--Recent Highlights and Changes
Chronic Obstructive Pulmonary Disease Pipeline Overview
--% of Projects (By Phase of Development)
--No. of Projects by Phase of Development
--Marketed Products Vs. Pipeline Products
Company Overview - Pipeline Projects
--Company Overview - Pipeline Projects
--Top Companies in late stage Chronic Obstructive Pulmonary Disease Projects
--Argenta Discovery Ltd.
--Alkermes Inc
--EpiGenesis Pharmaceuticals Inc
--Chiesi Farmaceutici S.p.A
--GlaxoSmithKline plc
--) Forest Laboratories Inc
--Milkhaus Laboratory, Inc.
--Laboratorios Almirall, S.A.
--NicOx S.A.
--Mitsubishi Tanabe Pharma Corporation
--Nycomed
--Novartis AG
--Pfizer Inc
--Otsuka Pharmaceutical Co., Ltd.
--SkyePharma Plc
--Schering-Plough Corp
--Teijin Pharma Limited
--Sosei Group Corporation
--Vectura Group plc.
--Theravance Inc
--Top Companies in early stage Chronic Obstructive Pulmonary Disease Projects
--Adenosine Therapeutics, LLC
--Abbott Laboratories
--Argenta Discovery Ltd.
--Aeolus Pharmaceuticals Inc
--AstraZeneca Plc
--Arriva Pharmaceuticals, Inc
--CyDex Pharmaceuticals, Inc.
--Chiesi Farmaceutici S.p.A
--GlaxoSmithKline plc
--EpiGenesis Pharmaceuticals Inc
--LigoCyte Pharmaceuticals, Inc.
--Laboratorios Salvat, S.A
--Orexo AB
--NeuroSearch A/S
--Quark Pharmaceuticals, Inc.
--Plexxikon Inc
--Silence Therapeutics plc
--erly SR Pharma plc)
--Sanofi-Aventis
--Vectura Group plc.
--TOPIGEN Pharmaceuticals Inc.
Pipeline Revenue
--Pipeline Revenue
Full Pipeline View
--Pre Clinical Pipeline View
--Phase I Pipeline View
--Phase II Pipeline View
--Phase III Pipeline View
--Pending Approval Pipeline View
--Post Marketing Pipeline View
--On the Market Pipeline View
--Discovery/Development Pipeline View
Customers who bought this item also bought
All rights reserved. © Copyright 2013 Research and Markets WWW4
Terms and Conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network
